The S.E.C. alleged shortcomings in research said to support the drug, and its developer agreed to a $40 million settlement. Some experts wonder why clinical trials have not been stopped.
Related Posts
Kennedy Attends Funeral in Texas of Girl Who Died of Measles
The health secretary has faced harsh criticism for his handling of the multistate outbreak, embrace of alternative treatments and tepid…
Judge Says Government Should Release Russian Scientist
The judge ordered ICE to release Kseniia Petrova, a researcher at Harvard Medical School, who also faces criminal charges.
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?
Most people, study after study shows, don’t take the medicines prescribed for them. It doesn’t matter what they are —…